Viking Therapeutics, Inc. (VKTX) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Viking Therapeutics, Inc. (VKTX) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

VKTX Income Statement

Viking Therapeutics, Inc. (VKTX) annual income statement — 14-year revenue, gross profit & net income history

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21

Sales/Revenue	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Revenue Growth %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Goods Sold	0	0	0	94K	114K	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
COGS % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	-94K	-114K	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Gross Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit Growth %	100%	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	100%
Operating Expenses	187.11M	132.6M	164.13M	164.74M	98.56M	74.57M	55.47M	46.24M	36.56M	34.05M	34.07M	29.29M	27.27M	23.74M	20.54M	20.28M	16.2M	17.63M	16.25M	12.51M
OpEx % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Selling, General & Admin	20.31M	16.84M	13.97M	11.28M	8.61M	14.42M	14.08M	15.25M	13.77M	10.29M	9.97M	8.78M	8.89M	9.82M	9.53M	4.11M	4.24M	4.09M	3.69M	2.66M
SG&A % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Research & Development	166.8M	115.75M	150.15M	153.46M	89.95M	60.15M	41.39M	30.99M	22.79M	23.77M	24.1M	20.5M	18.38M	13.92M	11.01M	16.18M	11.96M	13.54M	12.55M	9.85M
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Operating Income	-187.11M	-132.6M	-164.13M	-164.74M	-98.56M	-74.57M	-55.47M	-46.24M	-36.56M	-34.05M	-34.07M	-29.29M	-27.27M	-23.74M	-20.54M	-20.28M	-16.2M	-17.63M	-16.25M	-12.51M
Operating Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income Growth %	-89.84%	-77.81%	-195.89%	-256.28%	-169.62%	-118.99%	-62.79%	-57.89%	-34.08%	-43.45%	-65.91%	-44.38%	-68.34%	-34.65%	-26.42%	-62.13%	-20.84%	-13.45%	-14.18%	-11.05%
EBITDA	-183.1M	-132.44M	-164.04M	-164.64M	-98.45M	-74.46M	-55.36M	-46.13M	-36.47M	-33.98M	-34M	-29.21M	-27.19M	-23.67M	-20.46M	-20.21M	-16.05M	-17.42M	-16.17M	-12.43M
EBITDA Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA Growth %	-85.99%	-77.86%	-196.33%	-256.93%	-169.95%	-119.14%	-62.82%	-57.91%	-34.12%	-43.57%	-66.13%	-44.53%	-69.38%	-35.86%	-26.58%	-62.55%	-20.45%	-12.62%	-14.21%	-11.08%
D&A (Non-Cash Add-back)	0	157K	85K	94K	114K	112K	111K	110K	87K	75K	74K	74K	73K	73K	72K	72K	142K	0	77K	76K
EBIT	-183.1M	-128.02M	-158.32M	-157.66M	-90.78M	-65.54M	-45.6M	-35.39M	-24.92M	-22.23M	-27.33M	-24.58M	-22.53M	-19.19M	-19.5M	-19.55M	-15.75M	-17.42M	-16.1M	-12.34M
Net Interest Income	3.93M	4.54M	5.8M	7.04M	7.76M	9.01M	9.84M	10.82M	11.51M	11.8M	6.72M	4.68M	4.73M	4.51M	1.01M	724K	423K	241K	154K	147K
Interest Income	4.01M	4.54M	5.8M	7.04M	7.77M	9.03M	9.86M	10.84M	11.53M	11.82M	6.75M	4.71M	4.73M	4.55M	1.03M	732K	450K	253K	154K	159K
Interest Expense	88K	0	0	0	8K	24K	24K	24K	24K	18K	28K	26K	2K	32K	28K	8K	27K	12K	0	12K
Other Income/Expense	3.93M	4.58M	5.8M	7.08M	7.77M	9.01M	9.84M	10.82M	11.62M	11.8M	6.72M	4.68M	4.73M	4.51M	1.01M	724K	423K	199K	142K	154K
Pretax Income	-183.19M	-128.02M	-158.32M	-157.66M	-90.79M	-65.56M	-45.63M	-35.42M	-24.94M	-22.25M	-27.36M	-24.61M	-22.53M	-19.23M	-19.53M	-19.56M	-15.77M	-17.43M	-16.1M	-12.36M
Pretax Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income Tax	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Effective Tax Rate %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
Net Income	-183.19M	-128.02M	-158.32M	-157.66M	-90.79M	-65.56M	-45.63M	-35.42M	-24.94M	-22.25M	-27.36M	-24.61M	-22.53M	-19.23M	-19.53M	-19.56M	-15.77M	-17.43M	-16.1M	-12.36M
Net Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income Growth %	-101.78%	-95.27%	-246.98%	-345.16%	-264.02%	-194.66%	-66.8%	-43.94%	-10.68%	-15.73%	-40.06%	-25.8%	-42.86%	-10.29%	-21.29%	-58.3%	-19.1%	-13.33%	-14.94%	-12.86%
Net Income (Continuing)	-183.19M	-128.02M	-158.32M	-157.66M	-90.79M	-65.56M	-45.63M	-35.42M	-24.94M	-22.25M	-27.36M	-24.61M	-22.53M	-19.23M	-19.53M	-19.56M	-15.77M	-17.43M	-16.1M	-12.36M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	-1.55	-1.10	-1.37	-1.38	-0.81	-0.58	-0.41	-0.32	-0.22	-0.20	-0.26	-0.25	-0.23	-0.19	-0.24	-0.25	-0.20	-0.23	-0.21	-0.16
EPS Growth %	-91.36%	-89.66%	-234.15%	-331.25%	-268.18%	-190%	-57.69%	-28%	4.35%	-5.26%	-8.33%	0%	-15%	17.39%	-14.29%	-56.25%	-17.65%	-15%	-10.53%	-6.67%
EPS (Basic)	-1.55	-1.10	-1.37	-1.38	-0.81	-0.58	-0.41	-0.32	-0.22	-0.20	-0.26	-0.25	-0.23	-0.19	-0.24	-0.25	-0.20	-0.23	-0.21	-0.16
Diluted Shares Outstanding	118.05M	115.92M	115.57M	114M	112.32M	112.13M	112.07M	111.34M	110.91M	110.39M	103.46M	100.11M	99.85M	99.01M	78.35M	76.59M	76.51M	77.03M	77.41M	76.91M
Basic Shares Outstanding	118.05M	115.92M	115.57M	114M	112.32M	112.13M	112.07M	111.34M	110.91M	110.39M	103.46M	100.11M	99.85M	99.01M	78.35M	76.59M	76.5M	77.03M	77.41M	76.91M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-